Description

QuidelOrtho Corporation: Initiation Of Coverage – How Long Will The Increasing Non-Respiratory Revenue Last?

QuidelOrtho reported total revenues of $3 billion for the full year 2023, a decrease of 26% from the previous year. The drop was largely attributed to a lower respiratory season in 2023 compared to the prior year, specifically in COVID-19 related testing. The company’s non-respiratory revenue segments, however, exhibited a growth of 5% for the year, suggesting potential opportunities in these areas. Nevertheless, QuidelOrtho fell short of Q4 expectations, primarily due to an optimistically forecasted endemic COVID-19 and flu season that didn’t quite match reality. Despite this, the company managed to gain market share in respiratory point-of-care products while maintaining pricing levels, hinting at appetizing aspects in the face of overall revenue decrease.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!